港股異動 | 醫思健康(2138.HK)漲超5% 預期4月份銷售額同比增加不少於75%
格隆匯6月15日丨醫思健康(2138.HK)現報12.9港元,漲5.39%,暫成交1035萬港元,最新市值143億港元。醫思健康昨日公佈,集團截至今年3月31日止年度初步未經審計的銷售額預期錄得不少於22億港元,同比增長不少於10%;預期4月份銷售額不少於2.3億港元,同比增加不少於75%。董事會認為,集團的整體運作和財務狀況保持穩健。展望將來,集團對未來數個季度的業務表現持樂觀態度。公司今日早間亦公佈,於6月15日,集團與賣方訂立該等協議,集團有條件同意收購該等目標公司51%股權(亨潤、溢豐、香港獸醫映像中心及鋒冠的統稱),總代價為現金6600萬港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.